Valine, a branched-chain amino acid, reduced HCV viral load and led to eradication of HCV by interferon therapy in a decompensated cirrhotic patient

Case Reports in Gastroenterology

Volumn 6, Issue 3, 2012, Pages 660-667

  Kawaguchi, Takumi ^a,b   Torimura, Takuji ^a,b   Takata, Akio ^a   Satomi, Susumu ^c   Sata, Michio ^a,b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Branched chain amino acid; Hepatitis C virus; Valine; Viral kinetics

Indexed keywords

ALPHA FETOPROTEIN; BETA INTERFERON; GLYCYRRHIZIC ACID; ISOLEUCINE; LEUCINE; PHENYLALANINE; TYROSINE; URSODEOXYCHOLIC ACID; VALINE; VIRUS RNA;

ABSENCE OF SIDE EFFECTS; AGED; AMINO ACID BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CHILD PUGH SCORE; DECOMPENSATED LIVER CIRRHOSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; VIRUS LOAD;

EID: 84873107823     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000343094     Document Type: Article

References (20)

1. Afdhal NH, McHutchison JG, Zeuzem S, et al: Hepatitis C pharmacogenetics: State of the art in 2010. Hepatology 2011;53:336-345
2. Akuta N, Suzuki F, Hirakawa M, et al: Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 2a high viral load and virological response to interferon-ribavirin combination therapy. Intervirology 2009;52:301-309
3. Cross TJ, Rashid MM, Berry PA, Harrison PM: The importance of steatosis in chronic hepatitis C infection and its management: A review. Hepatol Res 2010;40:237-247
4. Fattovich G, Covolo L, Bibert S, et al: IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Aliment Pharmacol Ther 2011;33:1162-1172
5. Kawaguchi T, Izumi N, Charlton MR, Sata M: Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology 2011;54:1063-1070
6. Kato A, Suzuki K: How to select BCAA preparations. Hepatol Res 2004;30S:30-35
7. Moriwaki H, Shiraki M, Fukushima H, et al: Long-term outcome of branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res 2008;38:S102-S106
8. Kumada H, Okanoue T, Onji M, et al: Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res 2010;40:8-13
9. Kakazu E, Kanno N, Ueno Y, Shimosegawa T: Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells. J Immunol 2007;179:7137-7146
10. Komatsu H, Nishihira T, Chin M, et al: Effect of valine-depleted total parenteral nutrition on fatty liver development in tumor-bearing rats. Nutrition 1998;14:276-281
11. Miyanari Y, Atsuzawa K, Usuda N, et al: The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007;9:1089-1097
12. Honda M, Takehana K, Sakai A, et al: Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C. Gastroenterology 2011;141:128-140, 140.e1-2
13. Yamamoto T, Azechi H, Board M: Essential role of excessive tryptophan and its neurometabolites in fatigue. Can J Neurol Sci 2012;39:40-47
14. Vallet-Pichard A, Mallet V, Nalpas B, et al: FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-36
15. Nakanishi C, Doi H, Katsura K, Satomi S: Treatment with L-valine ameliorates liver fibrosis and restores thrombopoiesis in rats exposed to carbon tetrachloride. Tohoku J Exp Med 2010;221:151-159
16. Hagiwara A, Nishiyama M, Ishizaki S: Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms. J Cell Physiol 2012;227:2097-2105
17. Kakazu E, Ueno Y, Kondo Y, et al: Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis. Hepatology 2009;50:1936-1945
18. Muto Y, Sato S, Watanabe A, et al: Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006;35:204-214
19. Liang CC, Liu CH, Lin YL, Liu CJ, Chiang BL, Kao JH: Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy. J Med Virol 2011;83:1212-1220
20. Kawaguchi T, Yoshida T, Harada M, et al: Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004;165:1499-1508.